CSPC Pharmaceutical Group (1093) Financial Statements

32 Followers

CSPC Pharmaceutical Group Financial Overview

CSPC Pharmaceutical Group's market cap is currently HK$81.56B. The company's EPS TTM is HK$0.34; its P/E ratio is 18.54; and it has a dividend yield of 2.70%. CSPC Pharmaceutical Group is scheduled to report earnings on May 27, 2026, and the estimated EPS forecast is HK$0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	HK$ 25.33B	HK$ 29.54B	HK$ 31.47B	HK$ 31.59B	HK$ 27.41B
Gross Profit	HK$ 16.62B	HK$ 20.67B	HK$ 22.19B	HK$ 22.73B	HK$ 20.79B
Operating Income	HK$ 3.87B	HK$ 5.45B	HK$ 7.01B	HK$ 6.93B	HK$ 6.14B
EBITDA	HK$ 5.24B	HK$ 7.18B	HK$ 8.59B	HK$ 8.85B	HK$ 7.57B
Net Income	HK$ 3.78B	HK$ 4.41B	HK$ 5.88B	HK$ 6.22B	HK$ 5.51B
Balance Sheet
Cash & Short-Term Investments	HK$ 8.87B	HK$ 7.75B	HK$ 13.09B	HK$ 13.87B	HK$ 10.73B
Total Assets	HK$ 46.72B	HK$ 44.36B	HK$ 46.28B	HK$ 41.18B	HK$ 34.68B
Total Debt	HK$ 641.38M	HK$ 507.33M	HK$ 706.90M	HK$ 582.54M	HK$ 93.87M
Net Debt	HK$ -5.45B	HK$ -5.86B	HK$ -11.31B	HK$ -9.72B	HK$ -9.17B
Total Liabilities	HK$ 12.15B	HK$ 10.52B	HK$ 11.26B	HK$ 10.06B	HK$ 7.91B
Stockholders' Equity	HK$ 33.19B	HK$ 32.24B	HK$ 33.20B	HK$ 29.77B	HK$ 25.94B
Cash Flow
Free Cash Flow	HK$ 3.99B	HK$ 1.74B	HK$ 2.29B	HK$ 6.62B	HK$ 2.88B
Operating Cash Flow	HK$ 5.90B	HK$ 4.26B	HK$ 4.18B	HK$ 8.10B	HK$ 4.64B
Investing Cash Flow	HK$ -4.13B	HK$ -4.41B	HK$ 607.27M	HK$ -7.19B	HK$ -637.33M
Financing Cash Flow	HK$ -2.44B	HK$ -5.11B	HK$ -2.30B	HK$ -1.95B	HK$ -2.20B

Currency in HKD

CSPC Pharmaceutical Group Earnings and Revenue History

Income Statement >

CSPC Pharmaceutical Group Debt to Assets

Balance Sheet >

CSPC Pharmaceutical Group Cash Flow

Cash Flow >

CSPC Pharmaceutical Group Forecast EPS vs Actual EPS

Earnings >